Table of Contents
Chapter 1. Global Implantable Cardioverter Defibrillators Market Executive Summary
1.1. Global Implantable Cardioverter Defibrillators Market Size & Forecast (2024-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product Type
1.3.2. By Type
1.3.3. By NYHA Class
1.3.4. By End-use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Implantable Cardioverter Defibrillators Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Implantable Cardioverter Defibrillators Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Prevalence of Cardiovascular Diseases
3.1.2. Technological Advancements in ICDs
3.1.3. Growing Awareness and Government Initiatives
3.2. Market Challenges
3.2.1. High Cost of ICDs and Associated Care
3.3. Market Opportunities
3.3.1. Expanding Healthcare Infrastructure in Emerging Markets
3.3.2. Aging Global Population
Chapter 4. Global Implantable Cardioverter Defibrillators Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Implantable Cardioverter Defibrillators Market Size & Forecasts by Product Type 2024-2032
5.1. Segment Dashboard
5.2. Global Implantable Cardioverter Defibrillators Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Transvenous Implantable Cardioverter-Defibrillators
5.2.2. Subcutaneous Implantable Cardioverter Defibrillators
Chapter 6. Global Implantable Cardioverter Defibrillators Market Size & Forecasts by Type 2024-2032
6.1. Segment Dashboard
6.2. Global Implantable Cardioverter Defibrillators Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Single Chamber ICDs
6.2.2. Dual Chamber ICDs
6.2.3. Biventricular Devices
Chapter 7. Global Implantable Cardioverter Defibrillators Market Size & Forecasts by NYHA Class 2024-2032
7.1. Segment Dashboard
7.2. Global Implantable Cardioverter Defibrillators Market: NYHA Class Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. NYHA Class II
7.2.2. NYHA Class III
Chapter 8. Global Implantable Cardioverter Defibrillators Market Size & Forecasts by End-use 2024-2032
8.1. Segment Dashboard
8.2. Global Implantable Cardioverter Defibrillators Market: End-use Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Hospitals
8.2.2. Ambulatory Surgical Centers
8.2.3. Others
Chapter 9. Global Implantable Cardioverter Defibrillators Market Size & Forecasts by Region 2024-2032
9.1. North America Implantable Cardioverter Defibrillators Market
9.1.1. U.S. Implantable Cardioverter Defibrillators Market
9.1.1.1. By Product Type breakdown size & forecasts, 2024-2032
9.1.1.2. By Type breakdown size & forecasts, 2024-2032
9.1.1.3. By NYHA Class breakdown size & forecasts, 2024-2032
9.1.1.4. By End-use breakdown size & forecasts, 2024-2032
9.1.2. Canada Implantable Cardioverter Defibrillators Market
9.2. Europe Implantable Cardioverter Defibrillators Market
9.2.1. U.K. Implantable Cardioverter Defibrillators Market
9.2.2. Germany Implantable Cardioverter Defibrillators Market
9.2.3. France Implantable Cardioverter Defibrillators Market
9.2.4. Spain Implantable Cardioverter Defibrillators Market
9.2.5. Italy Implantable Cardioverter Defibrillators Market
9.2.6. Rest of Europe Implantable Cardioverter Defibrillators Market
9.3. Asia-Pacific Implantable Cardioverter Defibrillators Market
9.3.1. China Implantable Cardioverter Defibrillators Market
9.3.2. India Implantable Cardioverter Defibrillators Market
9.3.3. Japan Implantable Cardioverter Defibrillators Market
9.3.4. Australia Implantable Cardioverter Defibrillators Market
9.3.5. South Korea Implantable Cardioverter Defibrillators Market
9.3.6. Rest of Asia Pacific Implantable Cardioverter Defibrillators Market
9.4. Latin America Implantable Cardioverter Defibrillators Market
9.4.1. Brazil Implantable Cardioverter Defibrillators Market
9.4.2. Mexico Implantable Cardioverter Defibrillators Market
9.4.3. Rest of Latin America Implantable Cardioverter Defibrillators Market
9.5. Middle East & Africa Implantable Cardioverter Defibrillators Market
9.5.1. Saudi Arabia Implantable Cardioverter Defibrillators Market
9.5.2. South Africa Implantable Cardioverter Defibrillators Market
9.5.3. Rest of Middle East & Africa Implantable Cardioverter Defibrillators Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Medtronic
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Boston Scientific
10.3.3. Abbott Laboratories
10.3.4. Biotronik
10.3.5. Philips Healthcare
10.3.6. Sorin Group (now part of LivaNova)
10.3.7. Zoll Medical Corporation
10.3.8. Nihon Kohden Corporation
10.3.9. MicroPort Scientific Corporation
10.3.10. LivaNova
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes